Phibro Animal Health Corporation (PAHC)
NASDAQ • Healthcare
Last close at October 23, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Phibro Animal Health Corporation keeps $5 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 4
in 11 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Phibro Animal Health beat expectations on both the top and bottom line in the fourth fiscal quarter of 2026, based on preliminary results reported August 26, 2026, with adjusted EPS of $0.85 topping the $0.71 estimate (+19%) and revenue of $396.7 million topping the $381.2 million estimate (+4.1%). Revenue rose ~5% to about $396.7 million from roughly $378.7 million a year ago, with the business spanning Animal Health, Mineral Nutrition, and Performance Products. Profitability metrics were reported at a gross margin of roughly 36% and an operating margin of about 11%, alongside gross profit of about $141.4 million and operating income of roughly $44.1 million. Net income increased ~26% year over year to about $21.7 million, up from roughly $17.2 million a year ago. Consensus for the next period calls for EPS of $0.79 on revenue of $376.0 million.
Next report — what to expect
Phibro Animal Health Corporation (PAHC) reports on November 4, 2026. Wall Street expects EPS of $0.77 on revenue of $381.7 million. For trailing context, revenue grew +4.8% year over year last quarter. PAHC has beaten EPS in 8 of 8 most recent quarters, putting focus on margins and segment demand.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation is a NASDAQ-listed healthcare company that develops, makes, and sells animal health and related specialty products, with $1.3 billion in FY2025 revenue. Its business spans pharmaceuticals, biologics, mineral nutrition, and specialty ingredients used in livestock production and selected non-animal end markets.
Today's Snapshot
PAHC closed 2.5% below yesterday's close, in line with a weaker sector. Shares changed hands at about half of its usual level.
Trading Volume
Below 10d avg (213.0K)
102.7K
vs S&P 500 Today
Underperforming Market
-2.02%
Updated: October 23, 2026 at 20:18 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$36.87 - $40.08Buy
- RSI (14)58.01Neutral
- Stochastic %K (14, 3, 3)72.21Neutral
- MACD Level (12, 26)0.88Buy
Peers & Related Assets
Get premium market insights delivered directly to your inbox.